All articles tagged: Dermatophytosis, unspecified (B35.9)
Evalytics
19 March at 06.36 AM
The growing threat of fungal infectionsTwo converging crises are exacerbating the challenges posed by fungal infections, according to experts. First, as humans live longer but grapple with a higher prevalence of health conditions like obesity, diabetes, and inflammatory diseases, our susceptibility to fungal infections increases. These conditions create an environment where fungi can thrive, finding hospitable hosts in our bodies. |
|
Evalytics
14 February at 06.42 PM
The threat of fungal infections is growing. Why is it so hard to make new drugs?The FDA approves new drugs, such as Olorofim, to treat rare and serious fungal infections. Olorofim offers hope for patients with limited treatment options due to resistance or toxicity concerns. These advancements mark progress in addressing challenging fungal infections and improving patient outcomes. |
HealthDay
25 January at 10.55 PM
Microbial Contamination Prompts Recall of Robitussin Honey Cough SyrupEight lots of Robitussin Honey CF Max Day Adult and Robitussin Honey CF Max Nighttime Adult cough syrups have been recalled due to possible contamination.The products, which are made by Haleon, may be contaminated with a microbe, and "in immunocompromised individuals, the use of the affected product could potentially result in severe or life-t |
|
Evalytics
15 January at 04.33 PM
New estimate doubles likely deaths from fungal disease globallyThe article reports that global annual deaths from fungal diseases have risen to 3.75 million, double previous estimates. This finding, from a study led by Professor David Denning and involving over 300 professionals, highlights the significant, often underestimated impact of fungal diseases worldwide. |
Medical xPress
30 June at 07.40 AM
Decision to offer sedation for often-painful IUD insertion is 'groundbreaking,' health experts sayIntrauterine devices (IUDs) are a highly effective and long-lasting form of birth control placed in the uterus. Research shows that many people who get IUDs experience moderate to intense pain during the insertion. But it wasn't until recently that providers began to acknowledge this and do something about it. |
|
HealthDay
27 June at 03.19 PM
Immunoglobulin Replacement Therapy Beneficial for Blood CancersImmunoglobulin replacement therapy (IgRT) is associated with reductions in hypogammaglobulinemia, infections, severe infections, and associated antimicrobial use among real-world patients with chronic lymphocytic leukemia (CLL) or non-Hodgkin lymphoma (NHL), according to a study published online June 21 in Blood Advances.Jacob D. Soum |
Medpage Today
26 June at 04.59 PM
When Was the Last Time You Really Talked With Your Patient?My 10 o'clock patient's name is Maria*. Her chart has three "health maintenance" flags that are bright red, indicating that she is more than 3 years overdue for a mammogram, more than 6 years overdue for a Pap smear, and has... |
|
Medpage Today
23 June at 09.21 PM
Novel Triple-Hormone Agonist Boosts Beta-Cell Function in T2DORLANDO -- An investigational triple-hormone receptor agonist improved metabolic profiles of people with obesity with or without type 2 diabetes, an exploratory biomarker analysis of a phase II trial found. After 36 weeks... |
|
Medpage Today
22 June at 06.00 PM
Fenofibrate Slows Diabetic Retinopathy ProgressionORLANDO -- The cholesterol drug fenofibrate reduced progression of early eye disease among diabetes patients, the LENS trial showed. The fibrate reduced progression of early diabetic retinopathy or maculopathy by a relative... |
|
Medpage Today
22 June at 06.00 PM
Preventing Surgical-Site Infections; Drugs Go Head to Head for Ischemic StrokeTTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center... |
|
|
Medical xPress
22 June at 05.20 PM
Lawsuit could challenge trust in Ozempic and other popular weight loss drugsThe manufacturers of the most popular weight loss drugs are being challenged in court. |
|
HealthDay
21 June at 03.38 PM
Overall Prevalence of Being Up-to-Date With Lung Cancer Screening Is LowThe overall prevalence of up-to-date (UTD) lung cancer screening (LCS) was low in 2022, with prevalence increasing with age and number of comorbidities, according to a study published online June 10 in JAMA Internal Medicine.Priti Bandi, Ph.D., from the American Cancer Society in Atlanta, and colleagues estimated the contemporary preval |
|
Medpage Today
13 June at 06.56 PM
Upping Immunotherapy Activity; A Win for Lung Screening; Looming Drug Price Break?Finding a way to dissociate the activity of effector T cells from regulatory T cells could make immune checkpoint inhibitors more effective in the 60% of melanoma patients who do not benefit or develop resistance to the drugs... |
|
Medpage Today
08 June at 04.00 PM
Here Are the Top Supreme Court Health Cases to WatchBy early July, the Supreme Court will release its most controversial rulings for the 2023-2024 term. The Court's 6-3 conservative supermajority has already overturned Roe v. Wade, sharply limited affirmative action, expanded... |
Newsletter for Healtcare
Join over 1.2M subscribers and receive one weekly email.
